TheiaNova

TheiaNova is a University of Auckland spin-out, founded in 2022, developing TN-001, a first-in-class regenerative eyedrop that combines TGF-beta 3 with dexamethasone to regenerate corneal collagen and halt the progression of keratoconus, a progressive eye disease with no cure. The Auckland-based company dosed the first patient in a first-in-human proof-of-concept trial of TN-001 in January 2026 at a single Australian site, with promising early safety results. It is backed by Bridgewest Ventures and Booster Innovation Fund and is raising through a Snowball Effect equity crowdfunding campaign.

  • Seed
  • Biotechnology
  • Clinical Trials
  • Healthtech
  • Healthcare & Life Sciences

1

Round

1

Industry

4

Tags

Nov 10, 2026

Latest raise

Funding activity · 1 round

Raise timeline

  1. Nov 10, 2026

    NZD 1.3M

    Seed

    • Bridgewest Ventures
    • Booster

    Article coming soon.

Pricing

Research TheiaNova — then scale the playbook

Public hubs orient you on the raise. Paid plans unlock live AI adoption signals across your market.

Enterprise

Custom pricing for unlimited scale. Let's talk.

Contact sales

Growth plan

For individuals and small teams getting started with AI buyer intelligence.

$149

/month

Features

  • Access to core AI adoption signals
  • 3–5 curated slices per week
  • 30–60 companies / week
  • AI Adoption Score
  • Deal-ready insights (why + pitch angle)
  • Basic filters (recency, slice, score)
  • CSV export
Most popular

Pro plan

For outbound teams and agencies that need more coverage and faster signal cadence.

$249

/month

Features

  • Everything in Growth, plus:
  • Full access to all slices
  • 60–120 companies / week
  • Higher-frequency signal updates
  • Priority / early signals (before Growth)
  • Advanced filters (industry, size, use case)
  • Deeper company insights
  • Faster export + bulk workflows

Act on this raise

See if TheiaNova is moving on AI

Funding is the starting point. VeilStrat shows whether capital is showing up as hiring, tools, and web activity you can sell into.

© 2026 VeilStrat. All rights reserved.All systems operational